Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...

An International Journal of Obstetric and Gynecology showed that recurrent preterm birth was more than three times as common ...

But that good arm can be strengthened. In our newly published research in the journal JAMA Neurology, we found that training the less-impaired arm in people living with chronic stroke can improve ...

Recent developments of interest in cardiovascular medicine ...

New AI model decodes brain signals captured noninvasively via EEG opens the possibility of developing future neuroprosthetics ...

By combining brain imaging with AI models, researchers have enriched our understanding of what babies are thinking and how ...

Research conducted by the Cyprus Institute of Neurology and Genetics gives hope for the effective treatment of aggressive and ...

Do you struggle to concentrate for more than a few minutes or find you can’t focus on even the most mundane task? You’re not alone, says Dr Sabina Brennan, a neuroscientist and assistant professor at ...

Hippocampi- targeted AAV-delivered BDNF gene therapy improves cognitive impairments in Alzheimer’s disease Alzheimer’s ...

The DGIST Center for Synapse Diversity and Specificity has identified MDGA2 as a novel causative gene for developmental and ...

Ultra-processed foods have more in common with cigarettes than vegetables, study finds - UPF consumption has been linked to ...

“In people with schizophrenia, lower oral microbiota diversity was associated with poorer cognitive performance,” Professor Tamura said. “This study offers a new perspective on the oral-brain axis and ...